Equitable Names Greg Boosin as Chief Marketing Officer
'Greg is a dynamic and proven marketing leader in the financial services industry, with experience delivering measurable go-to-market strategies and driving growth across multiple verticals,' said Lane. 'His strategic mindset and deep marketing expertise will further strengthen our brand, as Equitable continues to meet clients where they are — offering trusted guidance and innovative solutions to help them navigate their financial journeys with confidence."
In this role, Boosin will lead all aspects of Equitable's marketing strategy to support its Retirement and Wealth Management businesses, focused on accelerating business growth, deepening client engagement and increasing brand awareness. He has more than two decades of experience in the financial services industry, most recently serving as Executive Vice President of Global B2B & Product Marketing at Mastercard. During his nearly 20-year tenure with the firm, he built and led a global team across four business units and five regions, overseeing lead generation, sales enablement, client acquisition and go-to-market strategies. He also held senior leadership roles at Mastercard spanning marketing strategy, investor relations and merchant sales.
Boosin serves on the advisory boards of several marketing and advertising industry groups, including the International Advertising Association's North American B2B Marketing Operational Board and the ANA CMO Growth Council for B2B Marketing.
Boosin assumes the Chief Marketing Officer role from Connie Weaver, who joined Equitable in 2020 to launch and build its brand in the market. Weaver has a distinguished marketing career spanning more than four decades, having held senior leadership positions at TIAA, The Hartford, AT&T and Microsoft. Following her planned retirement from Equitable, Weaver intends to remain active by sharing her expertise on advisory boards and working with early-stage companies as a strategic marketing advisor.
'Connie's expertise and leadership were instrumental in transforming the marketing organization to support business growth and significantly increased Equitable's brand awareness as a leading provider in the retirement and wealth management industry,' said Lane. 'We wish Connie the very best as she embarks on her next chapter.'
About Equitable
Equitable, a principal franchise of Equitable Holdings, Inc. (NYSE: EQH), has been one of America's leading financial services providers since 1859. With the mission to help clients secure their financial well-being, Equitable provides advice, protection and retirement strategies to individuals, families and small businesses. Equitable has more than 8,000 employees and Equitable Advisors financial professionals and serves 3 million clients across the country. Please visit equitable.com for more information.
Reference to the 1859 founding applies specifically and exclusively to Equitable Financial Life Insurance Company. GE-8052485.1 (06/25) (06/35)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Why D-Wave Quantum Stock Skyrocketed 74.3% in the First Half of 2025 -- and What Comes Next
Key Points D-Wave Quantum stock saw some big swings across the stretch, but it managed to post huge gains in this year's first half. The launch of the company's Advantage2 quantum computing system helped power a massive rally for the stock. D-Wave stock has continued to rally early in 2025's second half and is now up approximately 1,230% over the last year. 10 stocks we like better than D-Wave Quantum › D-Wave Quantum (NYSE: QBTS) stock closed out 2025's first half with big gains. The quantum computing specialist's share price surged 74.3% across the stretch, according to data from S&P Global Market Intelligence. Over the same period, the S&P 500 index rose 5.5%. Despite some huge volatility in this year's first half, D-Wave Quantum's valuation rocketed higher thanks to some big announcements and increasing optimism surrounding the outlook for quantum computing technologies. The stock has also continued to climb early in the second half of 2025, and it's now up roughly 1,230% over the last year. D-Wave Quantum's impressive rally continued in 2025's first half After soaring 854% across last year's trading, D-Wave Quantum stock saw some volatility early in 2025's trading. The stock saw a big pullback after Nvidia CEO Jensen Huang said that expectations for very useful quantum computers arriving within the next 15 years were probably optimistic, but its share price saw a big rally in March after Huang indicated that he was wrong about his previous timeline for the trajectory of the technology. On May 20, D-Wave published a press release announcing that its 4,400+ qubit Advantage2 annealing quantum computer had been made available for commercial customers. The Advantage2 is capable of handling processing problems that are virtually impossible with traditional computers, and news the company had begun selling the systems helped spur a huge rally for the stock. What's next for D-Wave Quantum? With gains of 15.5% across July's trading so far, D-Wave Quantum stock has continued to be red hot early in this year's second half. Strong gains and new stock sales have pushed the company's market capitalization up to $5.3 billion, and the company is now valued at approximately 217 times this year's expected sales. D-Wave Quantum has a promising early position in the quantum computing space and could be able to tap into massive growth opportunities ahead. On the other hand, charting how the quantum-computing industry will unfold involves a tremendous amount of guesswork. While it's possible that D-Wave Quantum and other specialized players in the category will emerge as big winners over the long term, there's also significant competitive risk from larger, more resource-rich tech giants including Alphabet, IBM, and Microsoft. In the near term, D-Wave stock is likely to see high levels of volatility -- although there could be strong bullish support for its stock if it turns out that the Federal Reserve will issue multiple interest rate cuts this year. On a business-specific level, the company's next quarterly report is shaping up to be a very interesting one and could spur big moves for the stock. The report should provide investors with a look at the level of demand that D-Wave is seeing for its Advantage2 systems and offer some insight on what's next in the company's tech pipeline. Should you invest $1,000 in D-Wave Quantum right now? Before you buy stock in D-Wave Quantum, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and D-Wave Quantum wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,281!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,050,415!* Now, it's worth noting Stock Advisor's total average return is 1,059% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Alphabet, International Business Machines, Microsoft, and Nvidia. The Motley Fool recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. Why D-Wave Quantum Stock Skyrocketed 74.3% in the First Half of 2025 -- and What Comes Next was originally published by The Motley Fool
Yahoo
23 minutes ago
- Yahoo
Elevance Health Hit By Medicaid Troubles, Trims Outlook
Elevance Health Inc. (NYSE:ELV) shares plummeted nearly 12% on Thursday after the health insurer reported second-quarter 2025 adjusted earnings that missed analyst expectations and significantly lowered its full-year guidance, overshadowing strong revenue growth. The company reported second-quarter 2025 revenues of $49.42 billion, up 14.3% year over year, higher than the consensus of $48.34 billion. The increase was driven by higher premium yields in the Health Benefits segment, recently closed acquisitions, and growth in Medicare Advantage membership, partially offset by membership attrition in the Medicaid Health reported adjusted earnings of $8.84 per share, missing the consensus of $9.20. The benefit expense ratio was 88.9%, an increase of 260 basis points year over year, reflecting higher medical cost trend primarily in Medicaid business and ACA health plans. The operating expense ratio was 10.1 percent, an improvement of 160 basis points. The adjusted operating expense ratio was 10%, an improvement of 140 basis points, primarily driven by expense leverage associated with growth in operating revenue and ongoing expense discipline as the company prioritizes investments to support long-term strategy. View more earnings on ELV Health Benefits segment operating revenue was $41.6 billion in the second quarter of 2025, up 12% compared to the prior year quarter, driven primarily by higher premium yields, recently closed acquisitions, and growth in Medicare Advantage membership, partially offset by lower Medicaid membership. Medical membership totaled approximately 45.6 million, a decline of 212 thousand from the first quarter of 2025, driven by lower Medicaid membership and attrition resulting from lower effectuation rates in Individual ACA business. Operating revenue for Carelon was $18.1 billion, up 36%, driven by recent acquisitions in home health and pharmacy services, growth in CarelonRx product revenue, and the scaling of risk-based capabilities in Carelon Services. Guidance Elevance Health lowered its fiscal year 2025 adjusted earnings guidance from $34.15-$34.85 per share to approximately $30, versus the consensus of $34.40. 'We are updating our outlook to reflect elevated medical cost trends in ACA and slower rate alignment in Medicaid. While the external environment continues to evolve, we are focused on the areas within our control – managing healthcare costs, deploying targeted investments in advanced technology and value-based care delivery, and reinforcing the operational foundation that supports long-term value creation,' said Gail Boudreaux, President and CEO, in a statement on Thursday. Industry Context and Peer Impact This guidance shock from Elevance Health follows a similar move by Centene Corp (NYSE:CNC). Centene recently withdrew its entire 2025 GAAP and adjusted diluted EPS guidance. This decision by Centene was prompted by its initial review of 2025 industry data from Wakely, an independent actuarial firm. Centene's analysis indicated lower-than-anticipated market growth and significantly higher implied market morbidity (prevalence of illness) in their Health Insurance Marketplace states, leading to a substantial reduction in their expected risk adjustment revenue transfer. These events highlight a broader industry concern among health insurers regarding elevated medical costs and challenges in accurately predicting risk and pricing in government-sponsored programs like Medicaid and the ACA. Price Action: ELV stock is trading lower by 11.8% to $303.92 at last check Thursday. Read Next:Photo by Jonathan Weiss via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Elevance Health Hit By Medicaid Troubles, Trims Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
23 minutes ago
- Yahoo
Lemonade To Announce Second Quarter 2025 Financial Results
NEW YORK, July 17, 2025--(BUSINESS WIRE)--Lemonade, Inc. (NYSE: LMND) today announced it will release its second quarter 2025 financial results on Tuesday, August 5, 2025 prior to market open, and will host a conference call at 8:00 am Eastern time (5:00 am Pacific time) that same day to discuss the results. To register for this conference call, please use this link. Registrants will receive confirmation with dial-in details. Registrants may also dial in, toll-free, at (833) 470-1428 or at (404) 975-4839, conference ID: 820365. In addition to the dial-in options, shareholders can participate by going to to submit questions to Say prior to the earnings call. The Q&A platform will be open for question submission starting July 28, 2025 at 8:00 am ET. Shareholders will be able to submit and upvote questions until August 4, 2025 at 8:00 am ET. Shareholders can email support@ for any support inquiries. A live webcast of the conference call is available here, and will be available on the Lemonade Investor Relations website. About Lemonade Lemonade offers renters, homeowners, car, pet, and life insurance. Powered by artificial intelligence and social impact, Lemonade's full stack insurance carriers in the US and the EU replace brokers and bureaucracy with bots and machine learning, aiming for zero paperwork and instant everything. A Certified B-Corp, Lemonade gives unused premiums to nonprofits selected by its community, during its annual Giveback. Lemonade is currently available in the United States, Germany, the Netherlands, France, and the UK, and continues to expand globally. Follow Lemonade on X and Instagram for updates. Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this press release are forward-looking statements, including the date and time of the earnings call. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements expressed or implied to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to the following: our history of losses and that we may not achieve or maintain profitability in the future; our success and ability to retain and expand our customer base; the "Lemonade" brand may not become as widely known as incumbents' brands or the brand may become tarnished; the denial of claims or our failure to accurately and timely pay claims; our ability to attain greater value from each user; availability of reinsurance at current levels and prices; our exposure to counterparty risks; our limited operating history; our ability to manage our growth effectively; our proprietary artificial intelligence algorithms may not operate properly or as expected; the intense competition in the segments of the insurance industry in which we operate; our ability to maintain our risk-based capital at the required levels; our ability to expand our product offerings; the novelty of our business model and its unpredictable efficacy and susceptibility to unintended consequences; the possibility that we could be forced to modify or eliminate our Giveback; regulatory risks, related to the operation, development, and implementation of our proprietary artificial intelligence algorithms and telematics based pricing model; legislation or legal requirements that may affect how we communicate with customers; the cyclical nature of the insurance industry; our reliance on artificial intelligence, telematics, mobile technology, and our digital platforms to collect data that we utilize in our business; our ability to obtain additional capital to the extent required to grow our business, which may not be available on terms acceptable to us or at all; our actual or perceived failure to protect customer information and other data as a result of security incidents or real or perceived errors, failures or bugs in our systems, website or app, respect customers' privacy, or comply with data privacy and security laws and regulations; periodic examinations by state insurance regulators; underwriting risks accurately and charging competitive yet profitable rates to customers; our ability to underwrite risks accurately and charge competitive yet profitable rates to our customers; potentially significant expenses incurred in connection with any new products before generating revenue from such products; risks associated with any costs incurred and other risks as we expand our business in the U.S. and internationally; our ability to comply with extensive insurance industry regulations; our ability to comply with insurance regulators and additional reporting requirements on insurance holding companies; our ability to predict the impacts of severe weather events and catastrophes, including the effects of climate change and global pandemics, on our business and the global economy generally; increasing scrutiny, actions, and changing expectations on environmental, social, and governance matters; our agreement with General Catalyst as a synthetic agent may not function as expected; fluctuations of our results of operations on a quarterly and annual basis; our utilization of customer and third party data in underwriting our policies; limitations in the analytical models used to assess and predict our exposure to catastrophe losses; potential losses could be greater than our loss and loss adjustment expense reserves; the minimum capital and surplus requirements our insurance subsidiaries are required to have; assessments and other surcharges from state guaranty funds; our status and obligations as a public benefit corporation; our operations in Israel and the current political, economic, and military instability, including the evolving conflict in Israel and surrounding region. These and other important factors described under the caption "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed on February 26, 2025, and in our other subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's beliefs as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. NEWS & INFORMATION DISCLOSURE Investors should note we may use our website ( blog ( X (@Lemonade_Inc), and LinkedIn as a means of disclosing information and for complying with our disclosure obligations under Regulation FD. The information we post through these channels may be deemed material. Investors should monitor these channels in addition to reviewing our press releases, SEC filings, and public conference calls. View source version on Contacts Press contact:Ilana ChernenkoPress@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati
